About

Maskmedic Pty Ltd is a private company established to commercialise new technologies developed by Professor Colin Sullivan for the diagnosis, treatment and monitoring of sleep disordered breathing (SDB).

Professor Sullivan invented and developed nasal continuous positive airway pressure (CPAP): the first successful non-invasive treatment of obstructive sleep apnea (OSA), a form of sleep disordered breathing.

News

May 2019 – A very interesting case report is published which illustrates how our mask helps an infant suffering from congenital central hypoventilation syndrome (CCHS) get better respiratory support.

23 September 2015 – We will be present at the ERS2015 – European Respiratory Society 2015 International Congress in Amsterdam, September 26-30 2015 .

14 July 2009 – The process for CE marking the Paediatric Concept™ Nasal Mask is completed, and the product is available for supply in Europe.

1 May 2009 – The Paediatric Concept™  Nasal Mask is listed on the Australian Register of Therapeutic Goods (ARTG), and is available for supply in Australia and New Zealand.

Customer Service

Maskmedic consists of a small but highly dedicated team focused on delivering innovative solutions to improve the quality of patients’ lives.

For more information, please contact us.